These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 18215605)

  • 21. Cost-effectiveness of aspirin treatment in the primary prevention of cardiovascular disease events in subgroups based on age, gender, and varying cardiovascular risk.
    Greving JP; Buskens E; Koffijberg H; Algra A
    Circulation; 2008 Jun; 117(22):2875-83. PubMed ID: 18506010
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost-effectiveness of sacral neuromodulation versus intravesical botulinum A toxin for treatment of refractory urge incontinence.
    Siddiqui NY; Amundsen CL; Visco AG; Myers ER; Wu JM
    J Urol; 2009 Dec; 182(6):2799-804. PubMed ID: 19837427
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost-effectiveness analysis of sacral neuromodulation (SNM) with Interstim for fecal incontinence patients in Spain.
    Brosa M; Muñoz-Duyos A; Navarro-Luna A; Rodriguez JM; Serrano D; Gisbert R; Dziekan K; Segú JL
    Curr Med Res Opin; 2008 Mar; 24(3):907-18. PubMed ID: 18279582
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Model-based simulation to explore the cost-effectiveness of following practice guidelines for triglyceride and low-density lipoprotein cholesterol control among patients with diabetes mellitus and mixed dyslipidemia.
    Sorensen SV; Frick KD; Wade A; Simko R; Burge R
    Clin Ther; 2009 Apr; 31(4):862-79. PubMed ID: 19446159
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost-effectiveness of group psychotherapy for depression in Uganda.
    Siskind D; Baingana F; Kim J
    J Ment Health Policy Econ; 2008 Sep; 11(3):127-33. PubMed ID: 18806302
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Critical pathway for the management of acute heart failure at the Veterans Affairs San Diego Healthcare System: transforming performance measures into cardiac care.
    Gardetto NJ; Greaney K; Arai L; Brenner A; Carroll KC; Howerton NM; Lee M; Pada L; Tseng M; Maisel AS
    Crit Pathw Cardiol; 2008 Sep; 7(3):153-72. PubMed ID: 18791404
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cost-effectiveness of preventive treatment of intracranial aneurysms: new data and uncertainties.
    Greving JP; Rinkel GJ; Buskens E; Algra A
    Neurology; 2009 Jul; 73(4):258-65. PubMed ID: 19299311
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of acute kidney injury in the intensive care unit: a cost-effectiveness analysis of daily vs alternate-day hemodialysis.
    Desai AA; Baras J; Berk BB; Nakajima A; Garber AM; Owens D; Chertow GM
    Arch Intern Med; 2008 Sep; 168(16):1761-7. PubMed ID: 18779463
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cost-effectiveness of intensive atorvastatin treatment in high-risk patients compared with usual care in a postgeneric statin market: economic analysis of the Aggressive Lipid-lowering Initiation Abates New Cardiac Events (ALLIANCE) study.
    Mullins CD; Rattinger GB; Kuznik A; Koren MJ
    Clin Ther; 2008; 30 Pt 2():2204-16. PubMed ID: 19281915
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Management programs for elderly patients with chronic heart failure].
    Pulignano G; Carmenini E; Del Sindaco D; Vlasic J; Tesorio MG; Di Luozzo M; Scherillo M; Giovannini E
    Clin Ter; 2003; 154(3):199-206. PubMed ID: 12910810
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cost-effectiveness of specialized multidisciplinary heart failure clinics in Ontario, Canada.
    Wijeysundera HC; Machado M; Wang X; Van Der Velde G; Sikich N; Witteman W; Tu JV; Lee DS; Goodman SG; Petrella R; O'Flaherty M; Capewell S; Krahn M
    Value Health; 2010 Dec; 13(8):915-21. PubMed ID: 21091970
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effectiveness of a multidimensional home nurse led heart failure disease management program--a French nationwide time-series comparison.
    Agrinier N; Altieri C; Alla F; Jay N; Dobre D; Thilly N; Zannad F
    Int J Cardiol; 2013 Oct; 168(4):3652-8. PubMed ID: 23809709
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tools for Economic Analysis of Patient Management Interventions in Heart Failure Cost-Effectiveness Model: A Web-based program designed to evaluate the cost-effectiveness of disease management programs in heart failure.
    Reed SD; Neilson MP; Gardner M; Li Y; Briggs AH; Polsky DE; Graham FL; Bowers MT; Paul SC; Granger BB; Schulman KA; Whellan DJ; Riegel B; Levy WC
    Am Heart J; 2015 Nov; 170(5):951-60. PubMed ID: 26542504
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Current perspectives in telemonitoring and devices in chronic heart failure patients: lights and shadows].
    Mortara A; Oliva F; Di Lenarda A
    G Ital Cardiol (Rome); 2010 May; 11(5 Suppl 2):33S-37S. PubMed ID: 20873466
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decision-analytic evaluation of the clinical effectiveness and cost-effectiveness of management programmes in chronic heart failure.
    Göhler A; Conrads-Frank A; Worrell SS; Geisler BP; Halpern EF; Dietz R; Anker SD; Gazelle GS; Siebert U
    Eur J Heart Fail; 2008 Oct; 10(10):1026-32. PubMed ID: 18760666
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heart failure management programs: can we afford to ignore the inpatient phase of care?
    McDonald K; Ledwidge M
    J Card Fail; 2003 Aug; 9(4):258-62. PubMed ID: 13680545
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The case-mix of chronic illness hospitalization rates in a managed care population: implications for health management programmes.
    Linden A; Goldberg S
    J Eval Clin Pract; 2007 Dec; 13(6):947-51. PubMed ID: 18070267
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Disease management programs: benchmarking costs, savings, ROI.
    Healthc Benchmarks; 1998 Aug; 5(8):117-9. PubMed ID: 10181998
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heart failure disease management programs: not a class effect.
    Fonarow GC
    Circulation; 2004 Dec; 110(23):3506-8. PubMed ID: 15583088
    [No Abstract]   [Full Text] [Related]  

  • 40. [Heart failure. Disease management program increases life expectancy].
    MMW Fortschr Med; 2004 Dec; 146(49):6. PubMed ID: 15646707
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.